SE has achieved rapid commercial success with VYVGART, driving $4.2 billion in 2025 sales and operational profitability. Learn more about ARGX stock here.

LAHORE: In a move that sets a new benchmark for delivery reliability in Pakistan’s automotive sector, MG Motor Pakistan has ...

Movies and popcorn are as iconic a pairing as Harry and Sally or Barbie and Ken.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. And many ...

The Millenia, a premium Grade A commercial campus by RMZ, Asia’s leading privately owned integrated alternative assets platform, in collaboration with Karnataka Vintage and Classic Car Club ...

Phase II showed a strong impact on MASH resolution at 24 weeks with good tolerability, and 48-week topline data reported continued weight loss and improved non-invasive anti-fibrotic signals ...

Great. Good morning, everyone. Thanks for joining us here at day 2 of the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink.

Tata Motors PV, with the new Punch EV, is doubling down on entry-level buyers, even as CAFE-III norms promise to rewrite the wider competitive calculus.

(ENXTBR:ARGX) has drawn fresh investor interest after reporting its first year of operating profitability and releasing positive Phase 3 VYVGART data in ocular myasthenia gravis, alongside plans for ...

JSW MG Motor India reassured customers with long-term ownership assurance through its unique 5-5-5 ownership programme for the MG MAJESTOR- India’s First D+ SUV. In a segment where customers invest ...

The LPG supply crunch amid global geopolitical tensions has hit the hospitality industry in the Delhi-NCR region with many small restaurants and cloud kitchens threatening to shut down within a week.

Northgate is consolidating its portfolio of businesses into Northgate Mobility in an effort to simplify its offering to customers. It will comprise Northgate Vehicle Hire, insurance replacement ...

Among patients with AD, receipt of JAK inhibitors was associated with an increased risk for acne compared with Th2 cytokine inhibitors.